Officials with the Creston Police Department report 23-year-old James Riddle, Jr., of Creston, was arrested a little after 6-a.m. today (Wednesday), for Driving While Suspended. Riddle was cited and released from the scene, on a Summons to Appear.

URBANA, Iowa – In an update to their previous report, the Iowa DCI, Tuesday, released an update on a Benton County death investigation. On January 1st, 2021, the Iowa Division of Criminal Investigation assisted the Urbana Police Department in the investigation of a possible murder/suicide. The Urbana Police Department received a 911 call from 59-year-old Garry Jensen, stating he had shot and killed his 54-year-old wife, Margaret. Law enforcement responded to the Jensen residence, located at 300 East Main Street in Urbana, and found Margaret Jensen deceased from an apparent gunshot wound. Garry Jensen was also located inside the residence deceased, with a self-inflicted gunshot wound.

The Iowa Office of the State Medical Examiner conducted autopsies on Margaret and Garry Jensen, and confirmed Margaret Jensen’s cause of death was the result of a gunshot wound and manner of death was homicide. Additionally, Garry Jensen’s death was ruled a suicide.

Assisting in the investigation was the Urbana Police Department, Iowa Office of the State Medical Examiner Office, Benton County Sheriff’s Office and the Benton County Attorney’s Office.

(Radio Iowa) – While select groups of Iowans are now getting COVID-19 vaccines developed by either Pfizer or Moderna, a third company’s vaccine is now going into the third phase of testing in Omaha/Council Bluffs. Dr. Diana Florescu, an infectious diseases specialist at the University of Nebraska Medical Center, says they’re grateful and excited to be chosen as a site for this important work.  Dr. Florescu says, “Our hope is that this vaccine will prevent people from developing severe disease and decrease the chances of being hospitalized or dying.”

A healthcare worker, left, is administered a shot of the Pfizer-BioNTech coronavirus vaccine at a mass vaccination center in Veghel, Netherlands, Wednesday Jan. 6, 2021. Nearly two weeks after most other European Union nations, the Netherlands on Wednesday began its COVID-19 vaccination program, with care home staff and frontline workers in hospitals first in line for the shot. (Piroschka van de Wouw/Pool via AP)

The investigational vaccine was developed by Novavax, a biotechnology company headquartered in Maryland. The Omaha-based hospital plans to enroll up to one-thousand study participants from Nebraska and Iowa.  “We encourage individuals who won’t be receiving the Pfizer or Moderna vaccines in the next three to six months to consider enrolling in the clinical trial,” Florescu says. “Participants in the Novavax vaccine clinical trial can still receive the Pfizer or Moderna vaccines when it is available to them and still remain in the trial.”

The Novavax vaccine is protein-based and an added component is designed to boost a person’s immune response to stimulate higher levels of antibodies. “Like everyone else, we want to beat this pandemic. To do so, we need multiple, safe and effective COVID-19 vaccines,” Florescu says. “We also want to involve the most vulnerable communities: minorities, people over the age of 65, and those with other health conditions.”

The vaccine does not contain live or inactivated virus, she says, so it does not cause infection. It requires two shots to be given three weeks apart. For more information, visit: unmc.edu/covidvaccinetrial